Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sertraline hydrochloride, quantity: 111.9 mg (equivalent: sertraline, qty 100 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; hyprolose; sodium starch glycollate; calcium hydrogen phosphate; macrogol 8000; hypromellose; macrogol 400; titanium dioxide; polysorbate 80 - children and adolescents: zoloft (sertraline hydrochloride) is indicated for the treatment of children (aged 6 years of age and older) and adolescents with ocd. adults: zoloft (sertraline hydrochloride) is indicated for the treatment of major depression, obsessive compulsive disorder (ocd) and panic disorder. zoloft (sertraline hydrochloride) is indicated for the treatment of social phobia (social anxiety disorder) and the prevention of its relapse. zoloft (sertraline hydrochloride) is indicated for the treatment of premenstrual dysphoric disorder (pmdd) as defined by dsm-iv criteria.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - oxytocin, quantity: 5 iu/ml - injection, solution - excipient ingredients: glacial acetic acid; chlorobutanol hemihydrate; water for injections; sodium acetate trihydrate; ethanol - induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - olopatadine hydrochloride, quantity: 1.11 mg/ml (equivalent: olopatadine, qty 1 mg/ml) - eye drops - excipient ingredients: sodium hydroxide; water for injections; dibasic sodium phosphate; benzalkonium chloride; sodium chloride; hydrochloric acid - for the treatment of the signs and symptoms of seasonal allergic conjunctivitis. treatment may be maintained for up to 14 weeks, if considered necessary.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - latanoprost, quantity: 50 microgram/ml - eye drops, solution - excipient ingredients: dibasic sodium phosphate; sodium chloride; benzalkonium chloride; monobasic sodium phosphate monohydrate; water for injections; hydrochloric acid; sodium hydroxide - reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - flucloxacillin, quantity: 500 mg - capsule, hard - excipient ingredients: brilliant blue fcf; erythrosine; magnesium stearate; gelatin; sodium lauryl sulfate; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia; potassium hydroxide - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - flucloxacillin, quantity: 250 mg - capsule, hard - excipient ingredients: titanium dioxide; erythrosine; brilliant blue fcf; gelatin; magnesium stearate; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; ethanol absolute; ammonia; potassium hydroxide - for the treatment of confirmed or suspected staphylococcal and other gram-positive coccal infections. indications include pneumonia, osteomyelitis, skin and soft tissue and wound infections, infected burns, cellulitis. changes made as described in the letter of 30/4/1998 from jason borg

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - oxytocin, quantity: 5 iu - injection, solution - excipient ingredients: glacial acetic acid; sodium acetate trihydrate; water for injections; sodium hydroxide - oxytocin is indicated for the induction of labour; inadequate uterine effort; management of third stage of labour; post-partum haemorrhage.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - hydrocortisone acetate, quantity: 10 % w/w - enema - excipient ingredients: cetyl alcohol; emulsifying wax; methyl hydroxybenzoate; propyl hydroxybenzoate; steareth-10; propylene glycol; trolamine; purified water; propane; isobutane - this product approved for registraiton as a variation of a product accepted for inclusion in the artg as 'currently supplied' at the commencement of the act. indications are held in artg paper records. previous product number aust r 15654. product information not reviewed. indications as at 21 august 1998: topical treatment of inflammation occurring in the rectal mucosa, eg ulcerative colitis, proctosigmoiditis and granular proctitis.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - amoxicillin trihydrate, quantity: 50 mg/ml - oral liquid, powder for - excipient ingredients: colloidal anhydrous silica; silicon dioxide; disodium edetate; sodium benzoate; xanthan gum; saccharin sodium; sorbitol; flavour - indications as at 6 november 2003: cilamox is indicated for the treatment of infections due to susceptible strains of the sensitive organisms. gram-negative: h. influenzae, e coli, pr. mirabilis, and n. gonorrhoeae. gram-positive: streptococcus species, s. pneumoniae, non-penicllinase producing staphlococci and bacillus anthracis. note 1: cilamox may be useful in instituting therapy prior to bacteriology; however, bacteriological studies to determine the causative organisms and their sensitivity to cilamox should be performed. note 2: penicillins are now generally regarded only as adjunctive to some other established first-line antibiotic therapy in the treatment and post-exposure prophylaxis of anthrax, because of concerns of constitutive and inducible beta-lactamase in bacillus anthracis. if use of amoxycillin is contemplated, appropriate bacteriological studies must be performed by a reliable and established test method. amoxycillin may then be suitable if the specific b. anthracis strain has been shown definitively to be sensitive to penicillin/amaxycillin.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - capecitabine, quantity: 150 mg - tablet, film coated - excipient ingredients: hypromellose; magnesium stearate; iron oxide yellow; microcrystalline cellulose; lactose; purified talc; titanium dioxide; iron oxide red; croscarmellose sodium; purified water - colon cancer:,capecitabine is indicated for the adjuvant treatment of patients with duke?s stage c and highrisk stage b, colon cancer, either as monotherapy or in combination with oxaliplatin.,colorectal cancer:,capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.,oesophagogastric cancer:,capecitabine is indicated for the first-line treatment of patients with advanced oesophagogastric cancer in combination with a platinum-based regimen.,breast cancer:,capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated.,capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.